Liam Condon Buys 5,226 Shares of Johnson Matthey (LON:JMAT) Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon acquired 5,226 shares of Johnson Matthey stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average price of GBX 1,923 per share, for a total transaction of £100,495.98.

Liam Condon also recently made the following trade(s):

  • On Wednesday, February 11th, Liam Condon purchased 10 shares of Johnson Matthey stock. The stock was acquired at an average cost of GBX 2,342 per share, with a total value of £234.20.
  • On Tuesday, January 13th, Liam Condon acquired 10 shares of Johnson Matthey stock. The shares were acquired at an average cost of GBX 2,321 per share, with a total value of £232.10.
  • On Wednesday, December 10th, Liam Condon bought 14 shares of Johnson Matthey stock. The stock was acquired at an average cost of GBX 2,013 per share, for a total transaction of £281.82.

Johnson Matthey Stock Performance

Shares of JMAT stock opened at GBX 1,953 on Tuesday. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. The business has a 50 day moving average of GBX 2,274.11 and a two-hundred day moving average of GBX 2,098.75. Johnson Matthey PLC has a 52 week low of GBX 1,131 and a 52 week high of GBX 2,434. The company has a market cap of £3.27 billion, a P/E ratio of -29.64, a PEG ratio of 49,242.50 and a beta of 0.95.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on JMAT shares. Berenberg Bank lowered their price objective on Johnson Matthey from GBX 2,100 to GBX 2,050 and set a “hold” rating for the company in a research note on Tuesday, November 25th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Johnson Matthey from GBX 2,300 to GBX 2,400 and gave the company a “buy” rating in a report on Wednesday, January 21st. Finally, Panmure Gordon restated a “buy” rating and set a GBX 2,370 price target on shares of Johnson Matthey in a research report on Monday, November 24th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of GBX 2,268.

Read Our Latest Analysis on Johnson Matthey

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Read More

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.